Loading video...
Video Failed to Load
Today we announced our initial post-approval access plans for our investigational HIV pre-exposure prophylaxis (PrEP). We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can quickly reach those who need it in low- and middle-income countries. Learn more:
13,686 views • 11 days ago •via X (Twitter)
0 Comments
No comments available
Comments from the original post will appear here






